Home › Funds › Bleichroeder LP › GNLX

Bleichroeder LP position in GNLX

GENELUX CORPORATION · Health Care

Bleichroeder LP reported holding 1,380,666 shares of GNLX (GENELUX CORPORATION) in its Q2 2026 13F filing — a position valued at US$4.2M, representing 0.74% of its reported portfolio and ranking #21 among its reported holdings. Bleichroeder LP has disclosed GNLX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.38M sh
Reported value held$4.16M
Portfolio Weight0.74%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bleichroeder LP's GNLX position evolved

Bleichroeder LP first disclosed a stake in GNLX in Q1 2025 at 714,000 shares (US$1.9M). The position peaked in Q2 2026 at 1,380,666 shares, worth US$4.2M. Across 6 filings, Bleichroeder LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 1,380,666 shares valued at US$4.2M. Notable position changes include a 93% increase in Q1 2026 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 714.00K $1.93M New
Q2 2025 714.00K $2.05M Hold
Q3 2025 714.00K $3.00M Hold
Q4 2025 714.00K $3.11M Hold
Q1 2026 1.38M $3.34M Add
Q2 2026 1.38M $4.16M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GNLX and 13F data

GNLX (GENELUX CORPORATION) is a Health Care company. 29 other funds we track also report a position in GNLX — the largest reported positions include WOODWARD DIVERSIFIED CAPITAL, LLC (US$6.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GNLX

All GNLX fund holders →

FAQ

How long has Bleichroeder LP held GNLX?

Bleichroeder LP has disclosed GNLX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Bleichroeder LP's current position in GNLX?

As of Q2 2026, Bleichroeder LP holds 1.38M shares of GNLX (GENELUX CORPORATION), valued at $4.16M, representing 0.74% of its reported portfolio and ranking #21.

Has Bleichroeder LP been buying or selling GNLX?

In the latest 13F filing (Q2 2026), Bleichroeder LP held unchanged its position in GNLX. The position peaked in Q2 2026 at 1.38M shares.

Which other funds hold GNLX?

Other major institutional holders of GNLX include WOODWARD DIVERSIFIED CAPITAL, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.